About BioDerm
BioDerm is a company based in Largo (United States) founded in 1991 was acquired by Mountaingate in January 2021. BioDerm has raised $603.85 thousand across 2 funding rounds from investors including Abacus Finance and Mountaingate Capital. The company has 73 employees as of December 31, 2022. BioDerm offers products and services including Silverlon Dressings, Anasept Cleanser, and Men’s Liberty Device. BioDerm operates in a competitive market with competitors including Camstent, NanoVibronix, ProvenMed, Aurie and FLUME, among others.
- Headquarter Largo, United States
- Employees 73 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$603.85 K (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Abacus Finance
& 1 more
-
Employee Count
73
as on Dec 31, 2022
-
Acquired by
Mountaingate
(Jan 11, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioDerm
BioDerm offers a comprehensive portfolio of products and services, including Silverlon Dressings, Anasept Cleanser, and Men’s Liberty Device.
Antimicrobial dressings for preventing infections in wounds
Cleanser that removes microorganisms from wound beds
External catheter for managing urinary incontinence
People of BioDerm
Unlock access to complete
Funding Insights of BioDerm
BioDerm has successfully raised a total of $603.85K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioDerm
BioDerm has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Abacus Finance and Mountaingate Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Abacus Finance is engaged in providing tailored credit solutions to lower-middle market companies.
|
Locked | Locked | Locked | |
|
Mountaingate Capital is engaged in private equity investments for growth-focused companies.
|
Locked | Locked | Locked |
Investor details for BioDerm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioDerm
Investment portfolio details for BioDerm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioDerm
Detailed financials for BioDerm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioderm Comparisons
Peer comparison for BioDerm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioDerm
BioDerm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Camstent, NanoVibronix, ProvenMed, Aurie and FLUME, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Polymer coating for medical devices
|
|
| Locked | Locked | Locked |
Provider of ultrasound therapy devices for multiple health purposes
|
|
| Locked | Locked | Locked |
Devices for urinary incontinence treatment are provided by ProvenMed.
|
|
| Locked | Locked | Locked |
Automated reusable self-catheter systems are developed for urinary retention patients.
|
|
| Locked | Locked | Locked |
Developer of a catheter for the treatment of urinary incontinence
|
Detailed competitors of BioDerm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioderm
Complete news archive for BioDerm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioDerm
BioDerm was founded in 1991 and raised its 1st funding round 20 years after it was founded.
BioDerm is headquartered in Largo, United States. It is registered at Largo, Florida, United States.
Gary Damkoehler is the current CEO of BioDerm.
BioDerm is a funded company, having raised a total of $603.85K across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at BioDerm is 73.
BioDerm was founded in 1991 and is headquartered in Largo, United States. Proprietary hydrocolloid-based medical devices are developed for urinary management, security, infection control, and skin protection within the healthcare sector. Key offerings include Mens Liberty, a male external catheter suited for community-dwelling men, and Safe n Dry, intended for institutional and hospital settings. Leadership is provided by Chairman and CEO Gary Damkoehler.
BioDerm's top competitors include NanoVibronix, Camstent and Aurie.
BioDerm offers Silverlon Dressings, Anasept Cleanser, and Men’s Liberty Device.
BioDerm has 2 investors. Key investors include Abacus Finance, and Mountaingate Capital.